Altered polarization, morphology, and impaired innate immunity germane to resident peritoneal macrophages in mice with long-term type 2 diabetes

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Liu, Hui Fang ^a   Zhang, Hui Jie ^a   Hu, Qi Xian ^a   Liu, Xiao Yan ^a   Wang, Zhi Quan ^a   Fan, Jia Yan ^a   Zhan, Ming ^a   Chen, Feng Ling ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CELL ADHESION; CELL COUNT; CELL PHAGOCYTOSIS; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; POLARIZATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL POLARITY; CELL SIZE; IMMUNOLOGY; PATHOLOGY; PERITONEUM;

MUS;

ANIMALS; CELL POLARITY; CELL SIZE; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; IMMUNITY, INNATE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; PERITONEUM;

EID: 84871832585     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/867023     Document Type: Article

References (42)

1. Fernández-Real J. M., Pickup J. C., Innate immunity, insulin resistance and type 2 diabetes. Diabetologia 2012 55 2 273 278 2-s2.0-84856750690 10.1007/s00125-011-2387-y
2. Tesch G. H., Role of macrophages in complications of Type 2 diabetes. Clinical and Experimental Pharmacology and Physiology 2007 34 10 1016 1019 2-s2.0-34547967661 10.1111/j.1440-1681.2007.04729.x (Pubitemid 47274561)
3. Lumeng C. N., Delproposto J. B., Westcott D. J., Saltiel A. R., Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008 57 12 3239 3246 2-s2.0-58149347227 10.2337/db08-0872
4. Lambrecht B. N., Alveolar macrophage in the driver's seat. Immunity 2006 24 4 366 368 2-s2.0-33645999061 10.1016/j.immuni.2006.03.008
5. Chang F. Y., Shaio M. F., Respiratory burst activity of monocytes from patients with non-insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice 1995 29 2 121 127 2-s2.0-0028881006 10.1016/0168-8227(95) 01123-4
6. Shurtz-Swirski R., Sela S., Herskovits A. T., Shasha S. M., Shapiro G., Nasser L., Kristal B., Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care 2001 24 1 104 110 2-s2.0-0035139127 (Pubitemid 32104229)
7. Wykretowicz A., Wierusz-Wysocka B., Wysocki J., Szczepanik A., Wysocki H., Impairment of the oxygen-dependent microbicidal mechanisms of polymorphonuclear neutrophils in patients with type 2 diabetes is not associated with increased susceptibility to infection. Diabetes Research and Clinical Practice 1993 19 3 195 201 2-s2.0-0027322658 10.1016/0168-8227(93)90114-K (Pubitemid 23176578)
8. Romano-Carratelli C., Galdiero M., Bentivoglio C., Nuzzo I., Cozzolino D., Torella R., HLA class II antigens and interleukin-1 in patients affected by type-II diabetes mellitus and hyperlipemia. Journal of Medicine 1993 24 1 28 34 2-s2.0-0027196555 (Pubitemid 23148703)
9. Ohno Y., Aoki N., Nishimura A., In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor- α in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1993 77 4 1072 1077 2-s2.0-0027369747 10.1210/jc.77.4.1072 (Pubitemid 23301488)
10. Kulseng B., Skjåk-BræK G., Følling I., Espevik T., TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide. Scandinavian Journal of Immunology 1996 43 3 335 340 2-s2.0-0029887804 (Pubitemid 26097605)
11. Martinez-Pomares L., Reid D. M., Brown G. D., Taylor P. R., Stillion R. J., Linehan S. A., Zamze S., Gordon S., Wong S. Y. C., Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies. Journal of Leukocyte Biology 2003 73 5 604 613 2-s2.0-0037824660 10.1189/jlb.0902450 (Pubitemid 38040473)
12. Volanakis J. E., The role of complement in innate and adaptive immunity. Current Topics in Microbiology and Immunology 2002 266 41 56 2-s2.0-0036214443 (Pubitemid 34297388)
13. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 1 23 35 2-s2.0-0037265240 10.1038/nri978 (Pubitemid 37328697)
14. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M., The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 2004 25 12 677 686 2-s2.0-7644231561 10.1016/j.it.2004.09. 015 (Pubitemid 39457982)
15. Mosser D. M., The many faces of macrophage activation. Journal of Leukocyte Biology 2003 73 2 209 212 2-s2.0-0037310024 10.1189/jlb.0602325 (Pubitemid 36158295)
16. Rezende T. M. B., Vargas D. L., Cardoso F. P., Sobrinho A. P. R., Vieira L. Q., Effect of mineral trioxide aggregate on cytokine production by peritoneal macrophages. International Endodontic Journal 2005 38 12 896 903 2-s2.0-28944451321 10.1111/j.1365-2591.2005.01036.x (Pubitemid 41784506)
17. Mantovani A., Sica A., Locati M., Macrophage polarization comes of age. Immunity 2005 23 4 344 346 2-s2.0-26644452073 10.1016/j.immuni.2005.10.001 (Pubitemid 41443435)
18. Steinman R. M., Moberg C. L., Zanvil Alexander Cohn 1926-1993. Journal of Experimental Medicine 1994 179 1 1 30 2-s2.0-0028141329
19. Turchyn L. R., Baginski T. J., Renkiewicz R. R., Lesch C. A., Mobley J. L., Phenotypic and functional analysis of murine resident and induced peritoneal macrophages. Comparative Medicine 2007 57 6 574 580 2-s2.0-38049030583
20. + macrophages: a study in mice with streptozotocin-induced diabetes for a long term. Journal of Molecular Medicine 2008 86 4 391 400 2-s2.0-42449117100 10.1007/s00109-008-0304-8
21. Cohn Z. A., Benson B., The differentiation of mononuclear phagocytes. morphology, cytochemistry, and biochemistry. The Journal of Experimental Medicine 1965 121 153 170
22. Ho W. Z., Lai J. P., Zhu X. H., Uvaydova M., Douglas S. D., Human monocytes and macrophages express substance P and neurokinin-1 receptor. Journal of Immunology 1997 159 11 5654 5660 2-s2.0-0031301905 (Pubitemid 127470097)
23. Bou Ghosn E. E., Cassado A. A., Govoni G. R., Fukuhara T., Yang Y., Monack D. M., Bortoluci K. R., Almeida S. R., Herzenberg L. A., Herzenberg L. A., Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proceedings of the National Academy of Sciences of the United States of America 2010 107 6 2568 2573 2-s2.0-77249144840 10.1073/pnas.0915000107
24. Imaizumi K., Kawabe T., Ichiyama S., Kikutani H., Yagita H., Shimokata K., Hasegawa Y., Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction. The American Journal of Physiology 1999 277 1, part 1 L49 L57 2-s2.0-0032808363 (Pubitemid 29356750)
25. Yang C., Zhou J. Y., Zhong H. J., Wang H. Y., Yan J., Liu Q., Huang S. N., Jiang J. X., Exogenous norepinephrine correlates with macrophage endoplasmic reticulum stress response in association with XBP-1. Journal of Surgical Research 2011 168 2 262 271 2-s2.0-79955820105 10.1016/j.jss.2009.10.002
26. Fujisaka S., Usui I., Bukhari A., Ikutani M., Oya T., Kanatani Y., Tsuneyama K., Nagai Y., Takatsu K., Urakaze M., Kobayashi M., Tobe K., Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009 58 11 2574 2582 2-s2.0-70350560546 10.2337/db08-1475
27. Shah B. R., Hux J. E., Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003 26 2 510 513 2-s2.0-0041308233 10.2337/diacare.26.2.510 (Pubitemid 36929083)
28. Nikolic T., Bunk M., Drexhage H. A., Leenen P. J. M., Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro. Journal of Immunology 2004 173 7 4342 4351 2-s2.0-4644363279 (Pubitemid 39280662)
29. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
30. Monney L., Sabatos C. A., Gaglia J. L., Ryu A., Waldner H., Chernova T., Manning S., Greenfield E. A., Coyle A. J., Sobel R. A., Freeman G. J., Kuchroo V. K., Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002 415 6871 536 541 2-s2.0-0037203867 10.1038/415536a (Pubitemid 34130609)
31. Chakraborty D., Banerjee S., Sen A., Banerjee K. K., Das P., Roy S., Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. Journal of Immunology 2005 175 5 3214 3224 2-s2.0-23844520264 (Pubitemid 41170542)
32. Sun C., Sun L., Ma H., Peng J., Zhen Y., Duan K., Liu G., Ding W., Zhao Y., The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term. Journal of Cellular Physiology 2012 227 4 1670 1679 2-s2.0-84855724917 10.1002/jcp.22891
33. Ferracini M., Martins J. O., Campos M. R. M., Anger D. B. C., Jancar S., Impaired phagocytosis by alveolar macrophages from diabetic rats is related to the deficient coupling of LTs to the Fc γ R signaling cascade. Molecular Immunology 2010 47 11-12 1974 1980 2-s2.0-77953615900 10.1016/j.molimm.2010.04. 018
34. Liu B. F., Miyata S., Kojima H., Uriuhara A., Kusunoki H., Suzuki K., Kasuga M., Low phagocytic activity of resident peritoneal macrophages in diabetic mice: Relevance to the formation of advanced glycation end products. Diabetes 1999 48 10 2074 2082 2-s2.0-0032882084 10.2337/diabetes.48.10.2074 (Pubitemid 29458374)
35. Sartipy P., Loskutoff D. J., Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2003 100 12 7265 7270 2-s2.0-0038809142 10.1073/pnas.1133870100 (Pubitemid 36706427)
36. Zhang Y., Guo K. Y., Diaz P. A., Heo M., Leibel R. L., Determinants of leptin gene expression in fat depots of lean mice. The American Journal of Physiology 2002 282 1 R226 R234 2-s2.0-0036084221 (Pubitemid 34663930)
37. Tomas E., Tsao T. S., Saha A. K., Murrey H. E., Zhang C. C., Itani S. I., Lodish H. F., Ruderman N. B., Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16309 16313 2-s2.0-0037059013 10.1073/pnas.222657499 (Pubitemid 35462791)
38. Stout R. D., Suttles J., Functional plasticity of macrophages: reversible adaptation to changing microenvironments. Journal of Leukocyte Biology 2004 76 3 509 513 2-s2.0-4344706372 10.1189/jlb.0504272 (Pubitemid 39129080)
39. Lee J. K., Ryu M. H., Byun J. A., Immunotoxic effect of β -chlorolactic acid on murine splenocyte and peritoneal macrophage function in vitro. Toxicology 2005 210 2-3 175 187 2-s2.0-17144388595 10.1016/j.tox.2005.01. 017 (Pubitemid 40517161)
40. Benoit M., Desnues B., Mege J. L., Macrophage polarization in bacterial infections. Journal of Immunology 2008 181 6 3733 3739 2-s2.0-56149103896
41. Murray P. J., Wynn T. A., Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology 2011 11 11 723 737 2-s2.0-80355131976 10.1038/nri3073
42. O'Connor J. C., Sherry C. L., Guest C. B., Freund G. G., Type 2 diabetes impairs insulin receptor substrate-2-mediated phosphatidylinositol 3-kinase activity in primary macrophages to induce a state of cytokine resistance to IL-4 in association with overexpression of suppressor of cytokine signaling-3. Journal of Immunology 2007 178 11 6886 6893 2-s2.0-34249823656 (Pubitemid 46847414)